Patents by Inventor Gino Tutera
Gino Tutera has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250006330Abstract: Systems and methods for providing a dosage on a device comprising an electronic circuit, an input device, and a display screen. The method includes receiving an input signal of a user indicating an input directed to a patient sex and patient status selected from the group comprising new patient, returning patient and booster patient. If the patient sex is female, an effective estradiol dosage and an effective testosterone dosage are determined using dosage calculation methods selected based on the patient status and additional female input parameters. If the patient sex is male an effective testosterone dosage is determined using dosage calculation methods selected based on the patient status and additional male input parameters.Type: ApplicationFiled: June 27, 2023Publication date: January 2, 2025Applicant: The SottoPelle Group, LLCInventor: Gino Tutera
-
Patent number: 12136474Abstract: A computer-implemented method of providing a dosage and a transgender patient treatment lifecycle comprising receiving, by a computerized device, an input signal of a user indicating an input directed to a patient sex and a patient status, wherein the patient status is automatically determined by the processor and includes at least one of a new patient, a returning patient and a booster patient, determining by the processor at least one of an effective estradiol dosage and an effective testosterone dosage using dosage calculation methods selected based on the patient status, automated male-to-female input parameters or automated female-to-male input parameters, and male-to-female or female-to-male tracking parameters in response to receiving an input indicating that the patient sex is male-to-female or female-to-male, displaying on the display screen, the determined effective dosages, and administering a pellet comprising at least one of the determined effective dosages to the patient.Type: GrantFiled: August 12, 2021Date of Patent: November 5, 2024Assignee: The SottoPelle Group, LLCInventors: Gino Tutera, Stephen Nunn
-
Publication number: 20240321414Abstract: A computer-implemented method of providing a dosage and a transgender patient treatment lifecycle comprising receiving, by a computerized device, an input signal of a user indicating an input directed to a patient sex and a patient status, wherein the patient status is automatically determined by the processor and includes at least one of a new patient, a returning patient and a booster patient, determining by the processor at least one of an effective estradiol dosage and an effective testosterone dosage using dosage calculation methods selected based on the patient status, automated male-to-female input parameters or automated female-to-male input parameters, and male-to-female or female-to-male tracking parameters in response to receiving an input indicating that the patient sex is male-to-female or female-to-male, displaying on the display screen, the determined effective dosages, and administering a pellet comprising at least one of the determined effective dosages to the patient.Type: ApplicationFiled: June 4, 2024Publication date: September 26, 2024Applicant: The SottoPelle Group, LLCInventors: Gino Tutera, Stephen Nunn
-
Publication number: 20240289699Abstract: A system and method for automatically calculating an accurate recommended dosage for hormone replacement therapy and automating the life cycle of a patient's treatment over time. The system and method can automatically acquire relevant patient parameters and apply a consistent formulaic approach to help reduce incorrect dosage determinations. A pellet insertion size may be determined and documented based on a calculated dosage, and an insertion side and lot numbers may be tracked and managed. In addition, corresponding revenues may be tracked and profitability may be reported for hormone replacement therapy practices.Type: ApplicationFiled: April 30, 2024Publication date: August 29, 2024Applicant: The SottoPelle Group, LLCInventor: Gino Tutera
-
Patent number: 11972369Abstract: A system and method for automatically calculating an accurate recommended dosage for hormone replacement therapy and automating the life cycle of a patient's treatment over time. The system and method can automatically acquire relevant patient parameters and apply a consistent formulaic approach to help reduce incorrect dosage determinations. A pellet insertion size may be determined and documented based on a calculated dosage, and an insertion side and lot numbers may be tracked and managed. In addition, corresponding revenues may be tracked and profitability may be reported for hormone replacement therapy practices.Type: GrantFiled: April 24, 2023Date of Patent: April 30, 2024Assignee: The SottoPelle Group, LLCInventor: Gino Tutera
-
Patent number: 11798659Abstract: A system and method for automatically calculating an accurate recommended dosage for hormone replacement therapy and automating the life cycle of a patient's treatment over time. The system and method can automatically acquire relevant patient parameters and apply a consistent formulaic approach to help reduce incorrect dosage determinations. A pellet insertion size may be determined and documented based on a calculated dosage, and an insertion side and lot numbers may be tracked and managed. In addition, corresponding revenues may be tracked and profitability may be reported for hormone replacement therapy practices.Type: GrantFiled: February 24, 2020Date of Patent: October 24, 2023Assignee: The Sotto Pelle Group, LLCInventor: Gino Tutera
-
Publication number: 20230259832Abstract: A system and method for automatically calculating an accurate recommended dosage for hormone replacement therapy and automating the life cycle of a patient's treatment over time. The system and method can automatically acquire relevant patient parameters and apply a consistent formulaic approach to help reduce incorrect dosage determinations. A pellet insertion size may be determined and documented based on a calculated dosage, and an insertion side and lot numbers may be tracked and managed. In addition, corresponding revenues may be tracked and profitability may be reported for hormone replacement therapy practices.Type: ApplicationFiled: April 24, 2023Publication date: August 17, 2023Applicant: The SottoPelle Group, LLCInventor: Gino Tutera
-
Patent number: 11727315Abstract: Systems and methods for providing a dosage on a device comprising an electronic circuit, an input device, and a display screen. The method includes receiving an input signal of a user indicating an input directed to a patient sex and patient status selected from the group comprising new patient, returning patient and booster patient. If the patient sex is female, an effective estradiol dosage and an effective testosterone dosage are determined using dosage calculation methods selected based on the patient status and additional female input parameters. If the patient sex is male an effective testosterone dosage is determined using dosage calculation methods selected based on the patient status and additional male input parameters.Type: GrantFiled: March 27, 2020Date of Patent: August 15, 2023Assignee: The SottoPelle Group, LLCInventor: Gino Tutera
-
Patent number: 11663529Abstract: A system and method for automatically calculating an accurate recommended dosage for hormone replacement therapy and automating the life cycle of a patient's treatment over time. The system and method can automatically acquire relevant patient parameters and apply a consistent formulaic approach to help reduce incorrect dosage determinations. A pellet insertion size may be determined and documented based on a calculated dosage, and an insertion side and lot numbers may be tracked and managed. In addition, corresponding revenues may be tracked and profitability may be reported for hormone replacement therapy practices.Type: GrantFiled: May 3, 2022Date of Patent: May 30, 2023Assignee: The SottoPelle Group, LLCInventor: Gino Tutera
-
Publication number: 20220270732Abstract: A system and method for automatically calculating an accurate recommended dosage for hormone replacement therapy and automating the life cycle of a patient's treatment over time. The system and method can automatically acquire relevant patient parameters and apply a consistent formulaic approach to help reduce incorrect dosage determinations. A pellet insertion size may be determined and documented based on a calculated dosage, and an insertion side and lot numbers may be tracked and managed. In addition, corresponding revenues may be tracked and profitability may be reported for hormone replacement therapy practices.Type: ApplicationFiled: May 3, 2022Publication date: August 25, 2022Applicant: The SottoPelle Group, LLCInventor: Gino Tutera
-
Patent number: 11393569Abstract: A system and method for automatically calculating an accurate recommended dosage for hormone replacement therapy and automating the life cycle of a patient's treatment over time. The system and method can automatically acquire relevant patient parameters and apply a consistent formulaic approach to help reduce incorrect dosage determinations. A pellet insertion size may be determined and documented based on a calculated dosage, and an insertion side and lot numbers may be tracked and managed. In addition, corresponding revenues may be tracked and profitability may be reported for hormone replacement therapy practices.Type: GrantFiled: February 24, 2020Date of Patent: July 19, 2022Assignee: The SottoPelle Group, LLCInventor: Gino Tutera
-
Publication number: 20210375405Abstract: A computer-implemented method of providing a dosage and a transgender patient treatment lifecycle comprising receiving, by a computerized device, an input signal of a user indicating an input directed to a patient sex and a patient status, wherein the patient status is automatically determined by the processor and includes at least one of a new patient, a returning patient and a booster patient, determining by the processor at least one of an effective estradiol dosage and an effective testosterone dosage using dosage calculation methods selected based on the patient status, automated male-to-female input parameters or automated female-to-male input parameters, and male-to-female or female-to-male tracking parameters in response to receiving an input indicating that the patient sex is male-to-female or female-to-male, displaying on the display screen, the determined effective dosages, and administering a pellet comprising at least one of the determined effective dosages to the patient.Type: ApplicationFiled: August 12, 2021Publication date: December 2, 2021Applicant: The SottoPelle Group, LLCInventors: Gino Tutera, Stephen Nunn
-
Publication number: 20200388367Abstract: A system and method for automatically calculating an accurate recommended dosage for hormone replacement therapy and automating the life cycle of a patient's treatment over time. The system and method can automatically acquire relevant patient parameters and apply a consistent formulaic approach to help reduce incorrect dosage determinations. A pellet insertion size may be determined and documented based on a calculated dosage, and an insertion side and lot numbers may be tracked and managed. In addition, corresponding revenues may be tracked and profitability may be reported for hormone replacement therapy practices.Type: ApplicationFiled: February 24, 2020Publication date: December 10, 2020Applicant: The SottoPelle Group, LLCInventor: Gino Tutera
-
Publication number: 20200227153Abstract: Systems and methods for providing a dosage on a device comprising an electronic circuit, an input device, and a display screen. The method includes receiving an input signal of a user indicating an input directed to a patient sex and patient status selected from the group comprising new patient, returning patient and booster patient. If the patient sex is female, an effective estradiol dosage and an effective testosterone dosage are determined using dosage calculation methods selected based on the patient status and additional female input parameters. If the patient sex is male an effective testosterone dosage is determined using dosage calculation methods selected based on the patient status and additional male input parameters.Type: ApplicationFiled: March 27, 2020Publication date: July 16, 2020Applicant: The SottoPelle Group, LLCInventor: Gino Tutera
-
Publication number: 20200219600Abstract: A system and method for automatically calculating an accurate recommended dosage for hormone replacement therapy and automating the life cycle of a patient's treatment over time. The system and method can automatically acquire relevant patient parameters and apply a consistent formulaic approach to help reduce incorrect dosage determinations. A pellet insertion size may be determined and documented based on a calculated dosage, and an insertion side and lot numbers may be tracked and managed. In addition, corresponding revenues may be tracked and profitability may be reported for hormone replacement therapy practices.Type: ApplicationFiled: February 24, 2020Publication date: July 9, 2020Applicant: The SottoPelle Group, LLCInventor: Gino Tutera
-
Patent number: 10642959Abstract: Systems and methods for providing a dosage on a device comprising an electronic circuit, an input device, and a display screen. The method includes receiving an input signal of a user indicating an input directed to a patient sex and patient status selected from the group comprising new patient, returning patient and booster patient. If the patient sex is female, an effective estradiol dosage and an effective testosterone dosage are determined using dosage calculation methods selected based on the patient status and additional female input parameters. If the patient sex is male an effective testosterone dosage is determined using dosage calculation methods selected based on the patient status and additional male input parameters.Type: GrantFiled: June 7, 2016Date of Patent: May 5, 2020Assignee: The SottoPelle Group, LLCInventor: Gino Tutera
-
Patent number: 10572628Abstract: A system and method for automatically calculating an accurate recommended dosage for hormone replacement therapy and automating the life cycle of a patient's treatment over time. The system and method can automatically acquire relevant patient parameters and apply a consistent formulaic approach to help reduce incorrect dosage determinations. A pellet insertion size may be determined and documented based on a calculated dosage, and an insertion side and lot numbers may be tracked and managed. In addition, corresponding revenues may be tracked and profitability may be reported for hormone replacement therapy practices.Type: GrantFiled: March 11, 2015Date of Patent: February 25, 2020Assignee: The SottoPelle Group, LLCInventor: Gino Tutera
-
Patent number: 10573409Abstract: A system and method for automatically calculating an accurate recommended dosage for hormone replacement therapy and automating the life cycle of a patient's treatment over time. The system and method can automatically acquire relevant patient parameters and apply a consistent formulaic approach to help reduce incorrect dosage determinations. A pellet insertion size may be determined and documented based on a calculated dosage, and an insertion side and lot numbers may be tracked and managed. In addition, corresponding revenues may be tracked and profitability may be reported for hormone replacement therapy practices.Type: GrantFiled: May 6, 2019Date of Patent: February 25, 2020Assignee: The SottoPelle Group, LLPInventor: Gino Tutera
-
Publication number: 20190333617Abstract: A system and method for automatically calculating an accurate recommended dosage for hormone replacement therapy and automating the life cycle of a patient's treatment over time. The system and method can automatically acquire relevant patient parameters and apply a consistent formulaic approach to help reduce incorrect dosage determinations. A pellet insertion size may be determined and documented based on a calculated dosage, and an insertion side and lot numbers may be tracked and managed. In addition, corresponding revenues may be tracked and profitability may be reported for hormone replacement therapy practices.Type: ApplicationFiled: May 6, 2019Publication date: October 31, 2019Applicant: The SottoPelle Group, LLCInventor: Gino Tutera
-
Patent number: 10325075Abstract: A system and method for automatically calculating an accurate recommended dosage for hormone replacement therapy and automating the life cycle of a patient's treatment over time. The system and method can automatically acquire relevant patient parameters and apply a consistent formulaic approach to help reduce incorrect dosage determinations. A pellet insertion size may be determined and documented based on a calculated dosage, and an insertion side and lot numbers may be tracked and managed. In addition, corresponding revenues may be tracked and profitability may be reported for hormone replacement therapy practices.Type: GrantFiled: May 25, 2016Date of Patent: June 18, 2019Assignee: The SottoPelle Group, LLCInventor: Gino Tutera